// App-Quantinova.ai

4562 : Predictive biomarkers in circulating tumor cells (CTC) from patients with castration-resistant prostate cancer (CRPC) through genomic analysis.

Researchers

Presenter

  • Daniel Costin Danila

Principal Investigators

  • Aseem Anand

  • Jianchao Yao

  • Magdalena Gierszewska

  • Melissa Kramer

  • Stephanie Muller

  • Martin Fleisher

  • William R. McCombie

  • Howard I. Scher

Medical Centers

  • Memorial Sloan Kettering Cancer Center, Port Washington, NY

  • Sidney Kimmel Center for Prostate and Urologic Cancers, Memorial Sloan-Kettering Cancer Center, New York, NY

  • Cold Spring Harbor Laboratory, Cold Spring Harbor, NY

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

  • Urology

Disease

  • Metastatic castration-resistant prostate cancer

Biomarkers

  • Circulating tumor cells

  • Cluster of differentiation 45

  • Epithelial Cell Adhesion Molecule

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved